| | | | | |
INBX Inhibrx Biosciences, Inc. Common Stock | €83,5071 | +2,87% | €1,23B | €51,77K | |
TMP Tompkins Financial Corporation | €85,6004 | -0,47% | €1,23B | €12,56K | |
BRUN Boost Run Inc. Class A Common Stock | €15,5434 | -9,99% | €1,23B | €563,01K | |
TWFG TWFG, Inc. Common Stock | €23,2765 | +1,31% | €1,23B | €43,53K | |
PCT PureCycle Technologies, Inc. Common stock | €5,9890 | +1,47% | €1,23B | €541,29K | |
REX REX American Resources Corp. | €37,9801 | +0,34% | €1,23B | €8,33K | |
NNNN Anbio Biotechnology Class A Ordinary Shares | €7,1626 | -0,01% | €1,23B | €13,41K | |
BTT BlackRock Municipal 2030 Target Term Trust | €19,4597 | +0,41% | €1,23B | €2,52K | |
ADNT Adient plc Ordinary Shares | €16,9178 | +1,23% | €1,23B | €33,20K | |
KALV KalVista Pharmaceuticals, Inc. Common Stock | €23,1547 | -0,04% | €1,23B | €1,57M | |
| €32,5410 | +0,99% | €1,23B | €61,04K | |
EMAT Evolution Metals & Technologies Corp. Common Stock | €2,3935 | -10,60% | €1,22B | €204,88K | |
DAO Youdao, Inc. American Depositary Shares, each representing one Class A Ordinary Share | €14,9772 | +2,63% | €1,22B | €6,99K | |
REPL Replimune Group, Inc. | €13,0246 | -2,55% | €1,22B | €889,60K | |
HCSG Healthcare Services Group | €20,1649 | +7,13% | €1,22B | €121,66K | |
